Fibrinolytic Beats Current Standard for Intermediate-Risk PE

REPATHA® CUTS RISK OF FIRST MAJOR CARDIOVASCULAR EVENTS BY 31% IN HIGH-RISK PATIENTS WITHOUT KNOWN SIGNIFICANT ATHEROSCLEROSIS

LAAC an Alternative for NOAC in Lower-Risk AF Patients

CHAMPION-AF study of the WATCHMAN FLX™ Left Atrial Appendage Closure Device as a first-line therapy for stroke risk reduction meets all primary and secondary safety and efficacy endpoints

Six Reasons Why CHAMPION-AF Should Not Change Practice

Anumana Secures FDA Clearance for First-of-Its-Kind ECG-AI Algorithm for Early Detection of Pulmonary Hypertension

HI-PEITHO trial demonstrates Boston Scientific EKOS™ Endovascular System is superior to standard of care for treatment of acute pulmonary embolism

FDA sees promise in voice-based AI model for heart failure

Mar 27 2026 This Week in Cardiology

Software errors lead to major insulin pump recall—manufacturer shares a fix